TNF and rheumatoid arthritis: An increased risk of serious bacterial infections in RA patients receiving TNFα blockers has also been established through two meta-analyses of randomized controlled trials [11,12] and retrospective cohort studies [13,14], although other studies gave contradictory results [15,16].